the present data show that the simultaneous administration of a pure antiandrogen neutralizes the influence of the transient increase in serum androgens on prostate cancer , as indicated by the 60 % decrease in serum prostatic acid phosphatase observed within 5 days of combined treatment with an lhrh agonist and a pure antiandrogen .
C0376358
prostate cancer
C0033572
prostatic